Page 693 - Read Online
P. 693

Page 6 of 12                                                  Fung et al. Hepatoma Res 2018;4:62  I  http://dx.doi.org/10.20517/2394-5079.2018.92



                             A


























                             B
























                             C
























               Figure 1. A: Cumulative incidence of HBsAg seroclearance after liver transplantation; B: cumulative incidence of the development of
               detectable anti-HBs after liver transplantation; C: cumulative incidence of recurrent hepatocellular carcinoma after transplantation
   688   689   690   691   692   693   694   695   696   697   698